Rhythm Biosciences Ltd has released a press release.
Appendix 4D & Interim Financial Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
In the deck
Earlier from Rhythm Biosciences
- RHY Institutional Presentation
- Appendix 4C - Quarterly
- Institutional Presentation
- Market Update
- RHY Continues Platform Expansion Program for Other Cancers
Later from Rhythm Biosciences
- Suspension from Official Quotation
- Update to TGA Submission
- Reinstatement to Official Quotation
- ColoSTAT abstracts accepted at 2023 ASCO Annual Meeting
- Executive Management Change
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences